Forward Look

Programs aim to increase awareness of benefits.

by Sue Rochman

Forward Look

New law mandates that cancer drugs get tested in kids in clinical trials.

by Sharon Tregaskis

Forward Look

Treating prostate cancer with fewer side effects.

by Bradley Jones

From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.

by Kendall K. Morgan

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann

Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor

A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.

by Cheryl Platzman Weinstock

In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

by Pamela Rafalow Grossman